Biological advances for new treatment approaches

Seminars in Oncology Nursing

Volumn 19, Issue 3, 2003, Pages 162-168

  Gemmill, Robin ^a,b   Idell, Cindy Smith ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIINFECTIVE AGENT; CANCER VACCINE; MONOCLONAL ANTIBODY; ENZYME INHIBITOR;

ANGIOGENESIS; CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER THERAPY; CARCINOGENESIS; CELL SURVIVAL; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ENZYME INHIBITION; GENE THERAPY; HUMAN; METASTASIS; NURSING; PATIENT EDUCATION; REVIEW; SIGNAL TRANSDUCTION; EDUCATION; IMMUNOTHERAPY; MULTIMODALITY CANCER THERAPY; ONCOLOGY NURSING;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CANCER VACCINES; COMBINED MODALITY THERAPY; ENZYME INHIBITORS; GENE THERAPY; HUMANS; IMMUNOTHERAPY; ONCOLOGIC NURSING; SIGNAL TRANSDUCTION;

EID: 0142026123     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-2081(03)00044-5     Document Type: Article

References (37)

1. Page R. Principles of Chemotherapy. Cancer Management: A Multidisciplinary Approach (ed 5). Available at: http://www.cancernetwork.com/ handbook/chemotherapy.htm. (accessed Sept 29, 2002)
2. Brown K., Esper P., Kelleher L., et al. Chemotherapy and Biotherapy Guidelines and Recommendations for Practice. 2001;Oncology Nursing Society, Pittsburgh, PA
3. Holland J. New treatment modalities in radiation therapy. J Intraven Nurs. 24:2001;95-101
4. Mendelsohn J. Targeting the epidermal growth factor receptor for cancer therapy. J Clin Oncol. 20:(suppl 18):2002;1s-13s
5. Davis T, Streicher H, Zwiebel J, et al. Biological Therapy. Cancer Management: A Multidisciplinary (ed 5). Available at: http://www.cancernetwork. com/handbook/chemotherapy.htm. (accessed Sept 30, 2002)
6. Kirkwood J. Immunotherapy of Cancer. Horizons in Cancer Therapeutics: From Bench to Bedside. 1:2000;6-11
7. Espinoza-Delgado I. Cancer vaccines. The Oncologist. 7:(suppl 3):2002;20-33
8. Marsa L: New Shot at Cancer: Experimental Vaccines Aimed Only at Malignant Cells Show Promise. Available at: http://www.latimes.com/features/ health/la-he-vaccines17mar. (accessed Mar 20, 2003)
9. Frijhoff A., Conti C., Senderowicz A. Second symposium of novel molecular targets for cancer therapy. The Oncologist. 7:(suppl 3):2002;1-3
10. Hanahan D., Weinberg R. The hallmarks of cancer. Cell. 100:2000;57-70
11. Grunwald V., Hidalgo M. The epidermal growth factor receptor A new target for anticancer therapy. Curr Probl Cancer. 26:2002;109-164
12. Baselga J. Why the epidermal growth factor receptor? The rationale for cancer therapy. The Oncologist. 7:(suppl 4):2002;2-8
13. Mendelsohn J., Dinney C. The Willet F. Whitmore Jr Lectureship Blockade of epidermal growth factor receptors as anticancer therapy. J Urol. 165:2001;1152-1157
14. Huang S.-M., Harari P.M. Epidermal growth factor receptor inhibition in cancer therapy Biology, rationale and preliminary clinical results. Invest New Drugs. 17:1999;259-269
15. Conti C. Vascular endothelial growth factor Regulation in the mouse skin carcinogenesis model and use in antiangiogenesis cancer therapy. The Oncologist. 7:(suppl 3):2002;4-11
16. Arteaga C. Epidermal growth factor receptor dependence in human tumors More than just expression? The Oncologist. 7:(suppl 4):2002;31-39
17. Waxman S., Herbst R. The role of the epidermal growth factor receptor in the treatment of colorectal carcinoma. Semin Oncol Nurs. 18:2002;20-29
18. Spencer-Cisek P. The role of growth factors in malignancy A focus on the epidermal growth factor receptor. Semin Oncol Nurs. 18:2002;13-19
19. Nahta R., Hortobagyi G., Esteva F. Growth factor receptors in breast cancer Potential for therapeutic intervention. The Oncologist. 8:2003;5-17
20. Teh B., Aguilar-Cordova E., Vlachaki M., et al. Combining radiotherapy with gene therapy - From the bench to the bedside A novel treatment strategy for prostate cancer. The Oncologist. 7:2002;458-466
21. McCarthy A. Making sense of antisense Genomics and cancer. Targeted Ther Oncol. 3:2003;3-4
22. Adams N. Summary of clinical data with ISIS 3521/LY900003. Targeted Ther Oncol. 3:2003;5-7
23. Heo D. Progress and limitations in cancer gene therapy. Genet Med. 4:(suppl 6):2002;52S-55S
24. Ellis L., Liu W., Fan F., et al. Role of angiogenesis inhibitors in cancer treatment. Oncology. 15:(suppl 8):2001;39-46
25. National Cancer Institute: Treating cancer with vaccine therapy. Available at: http://www.Cancersource.com (accessed June 26, 2003)
26. Industry watch Preliminary phase III results for Provenge vaccine in prostate cancer. Oncol News Intl. 11:2002;11
27. Chabner B. Cytotoxic agents in the era of molecular targets and genomics. The Oncologist. 7:(suppl 3):2002;34-41
28. Ciardiello F., Bianco R., Daminao V., et al. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. Clin Cancer Res. 5:1999;909-916
29. Kim E., Khuri F., Herbst R. Epidermal growth factor receptor biology (IMC-C225). Curr Opin Oncol. 13:2001;506-513
30. te Velde E.A., Vogten J.M., Gebbink M.F., et al. Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model. Br J Surg. 89:2002;1302-1309
31. Lin E. COX-2 inhibitor may boost capecitabine response. Oncol News Intl. 11:(suppl 5):2002;10
32. Ranson M. ZD 1839 (Iressa) For more than just non-small cell lung cancer. The Oncologist. 7:(suppl 4):2002;16-24
33. Groves M.D., Puduvalli V.K., Hess K.R., et al. Phase II trial of Temozolomide plus the matrix metalloproteinase inhibitor, Marimastat, in recurrent and progressive glioblastoma multiforme. J Clin Oncol. 20:2002;1383-1388
34. Senderowicz A. The cell cycle as a target for cancer therapy Basic and clinical findings with the small molecule inhibitors Flavopiridol and UCN-01. The Oncologist. 7:(suppl 3):2002;12-19
35. Dy G., Adjei A. Novel targets for lung cancer therapy Part I & II. J Clin Oncol. 20:2002;2881-2894., 3016-3028.
36. Yamamoto D., Hallquist P. Cyclooxygenase-2 From arthritis treatment to new indications for prevention and treatment of cancer. Clin J Oncol Nurs. 7:2003;21-29
37. Friedrich MJ: A genetic revolution in oncology: The impact on cancer nursing. Available at: http://www.cancersourcern.com (accessed Jan 15, 2003)